📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: EOS

1.1 - Company Overview

EOS Logo

EOS

Headquarter: Italy
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical research and development focused on creating novel medicines for the treatment of cancer.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to EOS

CytomX Therapeutics Logo

CytomX Therapeutics

HQ: United States Website
  • Description: Provider of proteolytically activated Probody therapeutics designed to activate only in cancer via tumor-specific proteases, minimizing activity in healthy tissue. Pipeline includes CX-904, a T-cell-engaging bispecific Probody targeting EGFR and CD3 in Phase 1 for advanced solid tumors; CX-2051, a conditionally activated EpCAM-targeting antibody-drug conjugate; and CX-801, an interferon alpha-2b Probody.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CytomX Therapeutics company profile →
Medfusion Services Logo

Medfusion Services

HQ: United States Website
  • Description: Provider of integrated clinical laboratory and clinical trial services, offering diagnostic testing (solid tumor, hematopathology, women's health, urology, general health), molecular diagnostics and test development, pathology services, and clinical trial support including specimen collection, processing, testing, and guidance for specimen packaging and shipping.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Medfusion Services company profile →
Juno Therapeutics Logo

Juno Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage immunotherapies for the treatment of cancer, formed through a unique partnership with Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center, and Seattle Children’s Research Institute to advance a broad pipeline of breakthrough immunotherapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Juno Therapeutics company profile →
Myelo Therapeutics Logo

Myelo Therapeutics

HQ: Germany Website
  • Description: Provider of treatments addressing high unmet medical needs, focused on developing myelo001, a small molecule effective on hematogenesis and investigated for its oral application in treating chemotherapy-induced myelosuppression, radiation-induced myelosuppression, and acute radiation syndrome. Founded in 2013 and based in Berlin, Germany.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Myelo Therapeutics company profile →
Immune-Onc Therapeutics Logo

Immune-Onc Therapeutics

HQ: United States Website
  • Description: Provider of therapeutic antibodies for cancer treatment, developing IO-202, a humanized IgG1 targeting LILRB4 to deplete LILRB4-expressing cells in blood cancers, autoimmune, and inflammatory diseases; IO-108, a fully human IgG4 targeting LILRB2 to block cancer-associated immune suppression in solid tumors; and IO-312, a bispecific targeting LILRB4 and CD3 for AML and other hematologic malignancies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Immune-Onc Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for EOS

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to EOS

2.2 - Growth funds investing in similar companies to EOS

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for EOS

4.2 - Public trading comparable groups for EOS

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to EOS

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About EOS

What does EOS do?

EOS is a provider of biopharmaceutical research and development focused on creating novel medicines for the treatment of cancer.

Who are EOS's competitors?

EOS's competitors and similar companies include CytomX Therapeutics, Medfusion Services, Juno Therapeutics, Myelo Therapeutics, and Immune-Onc Therapeutics.

Where is EOS headquartered?

EOS is headquartered in Italy.

How many employees does EOS have?

EOS has 1,000 employees 🔒.

When was EOS founded?

EOS was founded in 2010 🔒.

What sector and industry vertical is EOS in?

EOS is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for EOS

Who are the top strategic acquirers in EOS's sector and industry

Top strategic M&A buyers and acquirers in EOS's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for EOS?

Top strategic M&A buyers groups and sectors for EOS include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in EOS's sector and industry vertical

Which are the top PE firms investing in EOS's sector and industry vertical?

Top PE firms investing in EOS's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in EOS's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in EOS's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in EOS's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to EOS include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in EOS's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for EOS?

The key public trading comparables and valuation benchmarks for EOS include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for EOS for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for EOS with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in EOS's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for EOS with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in EOS's' sector and industry vertical?

Access recent funding rounds and capital raises in EOS's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for EOS